GSK reprimanded for unlicensed UK promotion of restless leg drug
British drugmaker GlaxoSmithKline has been reprimanded for promoting an unlicensed drug to treat the disputed condition of restless leg syndrome ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.